INCR · NASDAQ
Intercure (INCR) Stock Price & Fundamentals
Intercure (INCR) closed at $431.93 on Oct 9, 2026, up 1.24% from the previous close of $426.63.
Share price, past year
1Y +12.58%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $431.93 |
| Sep 30, 2026 | $408.07 |
| Aug 31, 2026 | $415.01 |
| Jul 31, 2026 | $416.14 |
| Jun 30, 2026 | $393.87 |
| May 29, 2026 | $407.44 |
| Apr 30, 2026 | $408.05 |
| Mar 31, 2026 | $402.64 |
| Feb 27, 2026 | $419.16 |
| Jan 30, 2026 | $388.12 |
| Dec 31, 2025 | $395.69 |
| Nov 28, 2025 | $386.91 |
| Oct 31, 2025 | $387.86 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 54.7M
- Dividend yield
- —
- 52-week range
- $377.99 – $431.93
Market cap, P/E and dividend yield aren't shown for Intercure yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Israeli new shekels.
Financials
Intercure reported revenue of ₪238.85M for fiscal 2024, down 32.82% from fiscal 2023.
Figures are in Israeli new shekels (ILS), as Intercure reports them to the SEC.
Intercure reported a net loss of ₪67.80M in fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | ₪238.85M | −32.8% | −₪67.80M | −28.4% | −₪1.48 | −₪71.30M |
| FY2023ended Dec 31, 2023 | ₪355.55M | −8.5% | −₪61.96M | −17.4% | −₪1.36 | −₪56.25M |
| FY2022ended Dec 31, 2022 | ₪388.68M | +76.9% | ₪44.82M | 11.5% | ₪0.99 | ₪31.53M |
| FY2021ended Dec 31, 2021 | ₪219.68M | +237.8% | ₪4.69M | 2.1% | ₪0.11 | ₪16.11M |
| FY2020ended Dec 31, 2020 | ₪65.04M | +628.6% | −₪37.23M | −57.3% | −₪1.42 | −₪12.95M |
| FY2019ended Dec 31, 2019 | ₪8.93M | — | −₪5.89M | −66.0% | −₪0.25 | −₪39.71M |
Company profile
- Name
- Intercure Ltd.
- Ticker
- INCR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 85 Medinat Ha-Yehudim Street, Herzliya, L3 4676670
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001857030
Recent SEC filings
- Apr 30, 2026
- May 1, 2025
- May 1, 2024
- May 1, 2023
- Apr 28, 2022
Frequently asked questions
What is Intercure's stock price?
Intercure (INCR) closed at $431.93 on Oct 9, 2026, up 1.24% from the previous close of $426.63.
How much revenue does Intercure make?
Intercure reported revenue of ₪238.85M for fiscal 2024, down 32.82% from fiscal 2023.
Sources and methodology
Fundamentals come from Intercure Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures